Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

VBI Vaccines and SciVac Therapeutics complete merger

May 10, 2016

CSIR discloses antimalaria compounds

May 10, 2016

Takeda partners with Gates Foundation on polio vaccine for developing countries

May 9, 2016

Monoclonal antibody targeting Chikungunya virus --SVIR-001-- reduces viral load in primate model

May 9, 2016

Shenzhen University patents piscidin analogues

May 6, 2016

NS4B inhibitor YF-01 demonstrates efficacy in a hamster model of YFV infection

May 6, 2016

Wellcome Trust award to advance development of Kineta's Lassa fever treatment

May 6, 2016

Phase I/IIa study of anti-RSV Nanobody meets primary endpoint

May 5, 2016

GlaxoSmithKline quadrivalent influenza vaccine safe, immunogenic in children under 3 years old

May 4, 2016

Arenavirus entry inhibitor from Kineta shows preclinical efficacy

May 3, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...